FDC Ltd successfully completes USFDA inspection at Baddi manufacturing facility

FDC Ltd has announced that U.S. Food and Drug Administration (FDA) had conducted an inspection at Company's manufacturing facility located at Baddi, Himachal Pradesh which is dedicated for manufacturing Cephalosporin Oral dosage forms.

The said audit has been successfully completed by the US FDA with "No observations" (Zero 483's).

Shares of FDC Limited was last trading in BSE at Rs. 535.80 as compared to the previous close of Rs. 530.75. The total number of shares traded during the day was 21649 in over 991 trades.

The stock hit an intraday high of Rs. 539.90 and intraday low of 523.80. The net turnover during the day was Rs. 11560433.00.

Source : Equity Bulls

Keywords

FDC INE258B01022 Baddi ManufacturingFacility Cephalosporin OralDosageForms USFDA Inspection Zero483 NoObservations